sar425899 sanofi dual glp-1 glucagon agonist Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes - Cheang - 2018 - ChemMedChem Role of a Dual Glucose-Dependent
Description
doi: 10.1002/14651858.CD006257.pub2
Patient preference data showing a strong bias towards oral therapies over injections 7,8 points to a broader redefinition of engagement, adherence and long-term management
For a definite out-of-pocket cost, call your insurance company
Pancreatitis: Inflammation of the pancreas
GLP-1 agonists are seen a lot in diabetes care, weight management and metabolic disorder therapies too
Meanwhile, GLP-1 receptor agonists are ideal for weight management before conception, especially in obese patients
